BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16885564)

  • 1. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression.
    Semba S; Huebner K
    Mol Cancer Res; 2006 Aug; 4(8):529-38. PubMed ID: 16885564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
    Oncogene; 2006 May; 25(20):2860-72. PubMed ID: 16407838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
    Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
    Pecherzewska R; Nawrot B
    Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
    Ottey M; Han SY; Druck T; Barnoski BL; McCorkell KA; Croce CM; Raventos-Suarez C; Fairchild CR; Wang Y; Huebner K
    Br J Cancer; 2004 Nov; 91(9):1669-77. PubMed ID: 15494723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.
    Sard L; Accornero P; Tornielli S; Delia D; Bunone G; Campiglio M; Colombo MP; Gramegna M; Croce CM; Pierotti MA; Sozzi G
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8489-92. PubMed ID: 10411902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Fhit-ing role in the DNA damage checkpoint response.
    Ishii H; Wang Y; Huebner K
    Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1.
    Huang Q; Xie F; Tang Z; Liu C; Wang C; Hu Y; Qiu L; Wang S; You H; Zhu K; Xu P
    Hepatogastroenterology; 2011; 58(107-108):713-8. PubMed ID: 21830375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor.
    Semba S; Han SY; Qin HR; McCorkell KA; Iliopoulos D; Pekarsky Y; Druck T; Trapasso F; Croce CM; Huebner K
    J Biol Chem; 2006 Sep; 281(38):28244-53. PubMed ID: 16864578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.
    Sevignani C; Calin GA; Cesari R; Sarti M; Ishii H; Yendamuri S; Vecchione A; Trapasso F; Croce CM
    Cancer Res; 2003 Mar; 63(6):1183-7. PubMed ID: 12649173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
    Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.
    Kim CH; Yoo JS; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Int J Cancer; 2006 Apr; 118(7):1692-8. PubMed ID: 16231322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.
    Cavazzoni A; Galetti M; Fumarola C; Alfieri RR; Roz L; Andriani F; Carbognani P; Rusca M; Sozzi G; Petronini PG
    Cancer Lett; 2007 Feb; 246(1-2):69-81. PubMed ID: 16616810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.
    Roz L; Gramegna M; Ishii H; Croce CM; Sozzi G
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3615-20. PubMed ID: 11891319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
    Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
    Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nit1 and Fhit tumor suppressor activities are additive.
    Sun J; Okumura H; Yearsley M; Frankel W; Fong LY; Druck T; Huebner K
    J Cell Biochem; 2009 Aug; 107(6):1097-106. PubMed ID: 19479888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberration of the enzymatic activity of Fhit tumor suppressor protein enhances cancer cell death upon photodynamic therapy similarly to that driven by wild-type Fhit.
    Ferens B; Kawiak A; Banecki B; Bielawski KP; Zawacka-Pankau J
    Cancer Lett; 2009 Jul; 280(1):101-9. PubMed ID: 19286306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.
    Roz L; Andriani F; Ferreira CG; Giaccone G; Sozzi G
    Oncogene; 2004 Dec; 23(56):9102-10. PubMed ID: 15489891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.